Effect of IL­-12 family cytokines on NK92 cells

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Osaka Dental University

• Publication date

  2017-10-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.18905/JODU.51.2_115
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The IL-23–IL-17 immune axis: from mechanisms to therapeutic testing

  2014cited by this paper
• IL-27 in tumor immunity and immunotherapy.

  2013cited by this paper
• Critical Role of Dendritic Cell–Derived IL-27 in Antitumor Immunity through Regulating the Recruitment and Activation of NK and NKT Cells

  2013cited by this paper
• New directions in the basic and translational biology of interleukin-27.

  2012cited by this paper
• IL-12 family cytokines: immunological playmakers

  2012cited by this paper
• Direct Recognition of Fusobacterium nucleatum by the NK Cell Natural Cytotoxicity Receptor NKp46 Aggravates Periodontal Disease

  2012cited by this paper
• Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily

  2011cited by this paper
• Regulation of human NK-cell cytokine and chemokine production by target cell recognition.

  2010cited by this paper
• CD56bright natural killer (NK) cells: an important NK cell subset

  2009cited by this paper
• Interleukin-27 activates natural killer cells and suppresses NK-resistant head and neck squamous cell carcinoma through inducing antibody-dependent cellular cytotoxicity.

  2009cited by this paper
• LFA-1 and CD2 Synergize for the Erk1/2 Activation in the Natural Killer (NK) Cell Immunological Synapse*

  2009cited by this paper
• Interleukin‐35: odd one out or part of the family?

  2008cited by this paper
• Human natural killer cells.

  2008cited by this paper
• Phenotypically and functionally distinct subsets of natural killer cells in human PBMCs

  2008cited by this paper
• The inhibitory cytokine IL-35 contributes to regulatory T-cell function

  2007cited by this paper
• Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis

  2007cited by this paper
• Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma.

  2006cited by this paper
• The IL-23/IL-17 axis in inflammation.

  2006cited by this paper
• Cytokines in atherosclerosis: pathogenic and regulatory pathways.

  2006cited by this paper
• Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.

  2005cited by this paper
• The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses.

  2003cited by this paper
• IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells.

  2002cited by this paper
• Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset

  2001cited by this paper
• CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells

  2001cited by this paper
• The biology of human natural killer-cell subsets.

  2001cited by this paper
• Elevated proportion of natural killer T cells in periodontitis lesions: a common feature of chronic inflammatory diseases.

  2001cited by this paper
• Differentiation of human NK cells into NK1 and NK2 subsets.

  1998cited by this paper
• Differential phenotypic properties of human peripheral blood CD56dim+ and CD56bright+ natural killer cell subpopulations.

  1996cited by this paper
• Human natural killer cells: origin, clonality, specificity, and receptors.

  1994cited by this paper
• The Role of the Host Response in Periodontal Disease Progression: Implications for Future Treatment Strategies.

  1993cited by this paper
• Immunopathogenesis of chronic inflammatory periodontal disease: cellular and molecular mechanisms.

  1993cited by this paper
• Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF

  1992cited by this paper
• Comparative studies of human FcRIII-positive and negative natural killer cells.

  1989cited by this paper

• Dual IL-2/IL-21 priming augments the anti-tumor function of CD16V-CAR/TRAIL-engineered NK cells in combination with monoclonal antibodies.

  2025cites this paper
• Cellular immunity analysis by a modular acoustofluidic platform: CIAMAP

  2023cites this paper
• The Crossroads of Periodontitis and Oral Squamous Cell Carcinoma: Immune Implications and Tumor Promoting Capacities

  2021cites this paper